Literature DB >> 17908160

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.

J J Carrero1, A R Qureshi, J Axelsson, M I Yilmaz, S Rehnmark, M R Witt, P Bárány, O Heimbürger, M E Suliman, A Alvestrand, B Lindholm, P Stenvinkel.   

Abstract

OBJECTIVES: In this study, we explore the associations of decreased thyroid hormone levels with inflammation, wasting and survival in biochemically euthyroid patients with end-stage renal disease (ESRD).
DESIGN: After exclusion of 23 patients with thyroid-stimulating hormone (TSH) values outside the normal range (0.1-4.5 mIU L(-1)), 187 clinically and biochemically euthyroid incident ESRD stage 5 patients starting dialysis were followed for a median of 20 (range 1-60) months. Measurements of total and free forms of thyroid hormones, s-albumin, hs-CRP, interleukin (IL)-6, vascular adhesion molecule (VCAM)-1 and insulin-like growth factor 1 (IGF-1) were performed at baseline.
RESULTS: In this population, 17 out of 210 patients (8%) were defined as subclinically hypothyroid. Multivariate analysis, according to receiver operating characteristic (ROC) curves, showed that mortality was best predicted by total triiodothyronine (T3). When using the cut-off levels derived from ROC, low T3 levels were associated with increased inflammation (higher hs-CRP, IL-6 and VCAM-1) and lower concentration of both s-albumin and IGF-1. Finally, low T3 but not low free triiodothyronine was associated with worse all-cause (Likelihood ratio = 45.4; P < 0.0001) and cardiovascular mortality (Likelihood ratio = 47.8; P < 0.0001) after adjustment for confounding factors.
CONCLUSION: This study showed that low T3 levels are independent predictors of all-cause and also cardiovascular disease mortality in biochemically euthyroid patients, perhaps due to an intimate association with inflammation. Based on these results, the use of T3 levels in studies assessing the relationship between thyroid dysfunction and mortality risk is recommended.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17908160     DOI: 10.1111/j.1365-2796.2007.01865.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  34 in total

Review 1.  Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.

Authors:  Alberto Ortiz; Ziad A Massy; Danilo Fliser; Bengt Lindholm; Andrzej Wiecek; Alberto Martínez-Castelao; Adrian Covic; David Goldsmith; Gültekin Süleymanlar; Gérard M London; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

2.  Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients.

Authors:  Erhan Tatar; Fatih Kircelli; Gulay Asci; Juan Jesus Carrero; Ozkan Gungor; Meltem Sezis Demirci; Suha Sureyya Ozbek; Naim Ceylan; Mehmet Ozkahya; Huseyin Toz; Ercan Ok
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

Review 3.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

4.  Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.

Authors:  Guliz Kozdag; Gokhan Ertas; Teoman Kilic; Eser Acar; Tayfun Sahin; Dilek Ural
Journal:  Tex Heart Inst J       Date:  2010

5.  Thyrotropin and free thyroxine concentrations do not affect cardiovascular disease and mortality in euthyroid peritoneal dialysis patients.

Authors:  Sara Romero Pérez; Juan Jose Díez; María Auxiliadora Bajo; Pedro Iglesias; Cristina Grande; Gloria del Peso; Rosario Madero; Marta Ossorio; Rafael Selgas
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

6.  Prevalence and clinical characteristics of hypothyroidism in a population undergoing maintenance hemodialysis.

Authors:  Klara Paudel
Journal:  J Clin Diagn Res       Date:  2014-04-15

7.  The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients.

Authors:  Erhan Tatar; Meltem Sezis Demirci; Fatih Kircelli; Ozkan Gungor; Mustafa Yaprak; Gulay Asci; Ali Basci; Mehmet Ozkahya; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2011-07-22       Impact factor: 2.370

8.  Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients.

Authors:  Tae Ik Chang; Joo Young Nam; Sug Kyun Shin; Ea Wha Kang
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

9.  Hypothyroidism and mortality among dialysis patients.

Authors:  Connie M Rhee; Erik K Alexander; Ishir Bhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

Review 10.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.